Send to

Choose Destination
See comment in PubMed Commons below
Neurology. 2005 Jan 25;64(2):353-5.

Efficacy of rapid IV administration of valproic acid for status epilepticus.

Author information

University of Alabama School of Medicine,Birmingham, AL, USA.


Although not approved by the US Food and Drug Administration for the treatment of status epilepticus (SE), valproic acid (VPA) is an emerging option for this purpose. The authors reviewed 63 patients (30 men) with SE treated with IV VPA (average dose, 31.5 mg/kg). Analysis of demographic, clinical, and treatment information indicated an overall efficacy of 63.3% and favorable tolerance of rapid administration.

[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Support Center